Molecular super enhancers: A new key for targeted therapy of brain cancer in children
Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer in children. The genetic causes for its development are largely unknown and there are no targeted treatments to date. Scientists have now developed a molecular approach that opens new treatment prospects. …read more
